TY  - JOUR
AU  - Berardi, Rossana
AU  - Santoni, Matteo
AU  - Rinaldi, Silvia
AU  - Bower, Marc
AU  - Tiberi, Michela
AU  - Morgese, Francesca
AU  - Caramanti, Miriam
AU  - Savini, Agnese
AU  - Ferrini, Consuelo
AU  - Torniai, Mariangela
AU  - Fiordoliva, Ilaria
AU  - Newsom-Davis, Thomas
PY  - 2019
TI  - Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer
JF  - Annals of Translational Medicine; Vol 7, No 20 (October 31, 2019): Annals of Translational Medicine
Y2  - 2019
KW  - 
N2  - Background: Inflammation plays an important role in pathogenesis, development and progression of lung cancer. The aim of the study is to assess the prognostic role of Systemic Immune-Inflammation Index (SII), obtained by analyzing the neutrophil, lymphocyte and platelet counts, and to design prognostic models for patients receiving first-line chemo- or targeted therapy for advanced non-small cell lung cancer (NSCLC).   Methods: We conducted an analysis on 311 patients with advanced NSCLC, treated with first line chemoor targeted therapy till June 2015 at our Institution. Patients were stratified in two groups with SII ≥1,270 (Group A) vs. SII 
UR  - https://atm.amegroups.org/article/view/29653